Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-095142
Filing Date
2022-04-04
Accepted
2022-04-04 16:37:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d19917ddefa14a.htm DEFA14A 16210
2 GRAPHIC g19917g36i61.jpg GRAPHIC 351279
3 GRAPHIC g19917g38n51.jpg GRAPHIC 385480
4 GRAPHIC g19917g86v94.jpg GRAPHIC 65272
  Complete submission text file 0001193125-22-095142.txt   1122459
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06571 | Film No.: 22802919
SIC: 2834 Pharmaceutical Preparations